|
|
 |
October
17 - 19, 2007
Venue location to be
announced |
| |
The pharma industry is experiencing
an unprecedented growth in the threat of counterfeit drugs
entering the legitimate supply chain. Patient’s lives are at risk
and companies are losing billions of dollars in sales due to fake
drugs flooding onto the market.
The FDA has just published their updated anti-counterfeiting
guidelines and announced they will fully implement the
Prescription Drug Marketing Act from December 2006. Will only drug
distributors be responsible to provide documented proof of the
‘chain of custody’ – or manufacturers too?
Driven by these and other international regulatory initiatives,
pharma is implementing anti-counterfeiting strategies, assessing
security packaging, tracking technologies and consulting
regulators to combat this fraud. |
|
Find Out More
>> |
|
